Cargando…
Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis
SUMMARY: Combined treatment with alendronate and eldecalcitol was found to be more effective in reducing the bone turnover markers and increasing bone mineral density than alendronate treatment with vitamin D3 and calcium supplementation in the osteoporotic patients. INTRODUCTION: We compared the cl...
Autores principales: | Sakai, A., Ito, M., Tomomitsu, T., Tsurukami, H., Ikeda, S., Fukuda, F., Mizunuma, H., Inoue, T., Saito, H., Nakamura, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331603/ https://www.ncbi.nlm.nih.gov/pubmed/25592133 http://dx.doi.org/10.1007/s00198-014-2991-z |
Ejemplares similares
-
Erratum to: Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis
por: Sakai, A., et al.
Publicado: (2015) -
Eldecalcitol, an active vitamin D analog, effectively prevents cyclophosphamide-induced osteoporosis in rats
por: Wang, Wei, et al.
Publicado: (2019) -
Inhibition of vitamin D analog eldecalcitol on hepatoma in vitro and in vivo
por: Ye, Limin, et al.
Publicado: (2020) -
Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials
por: Xu, Zhixing, et al.
Publicado: (2016) -
Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials [Corrigendum]
Publicado: (2016)